Tachykinin-dependent and -independent components of peristalsis in the guinea pig isolated distal colon☆☆☆
Abstract
Background & Aims: In the intestine, tachykinins regulate motility by participating in neuromuscular and neuro-neuronal transmission. The aim of this study was to test the hypothesis that colonic propulsion is regulated by an interplay between tachykinergic and cholinergic transmission. Methods: Propulsion was elicited by intraluminal distention of a thin rubber balloon, which traveled from the oral to the anal end of guinea pig isolated distal colon segments. The overall contribution of endogenous tachykinins to colonic propulsion was examined by blocking NK1, NK2, and NK3 receptors simultaneously. Results: NK2-receptor blockade by MEN 11420 inhibited propulsion, whereas blockade of NK1 by SR 140333 or of NK3 receptors by SR 142801 had minor effects on motility. Blockade of muscarinic or nicotinic receptors by hyoscine or hexamethonium decelerated peristalsis up to propulsion arrest. In the presence of partial muscarinic receptor blockade, the NK1-receptor antagonist SR 140333 and the NK2-receptor antagonist MEN 11420 markedly inhibited propulsion. Propulsion was also inhibited by the NK3-receptor antagonist SR 142801 in the presence of partial nicotinic receptor blockade. The simultaneous administration of the 3 tachykinin antagonists inhibited propulsion by 50%. Conclusions: This study demonstrates the existence of an interplay between tachykinergic and cholinergic pathways during peristalsis and the importance of endogenous tachykinins acting at multiple receptor sites in the control of colonic propulsion.
GASTROENTEROLOGY 2001;120:938-945
Abbreviations: ACh , acetylcholine, L-NOARG , NG-nitro-L-arginine
To access this article, please choose from the options below
☆ Supported by funds from the University of Pavia (FAR 1998) and CARIPLO Foundation (to M.T.), Italy, and Morphology/Imaging Core of CURE Digestive Diseases Research Center grants DK 54155 and 41301 (to C.S.).
☆☆ Address requests for reprints to: Marcello Tonini, Ph.D., Division of Clinical and Experimental Pharmacology, Department of Internal Medicine and Therapeutics, University of Pavia, Piazza Botta 10, I-27100 Pavia, Italy. e-mail: tonini@unipv.it; fax: (39) 0382-506419.
PII: S0016-5085(01)42709-0
© 2001 American Gastroenterological Association. Published by Elsevier Inc. All rights reserved.

